Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Kimihiro Shimizu"'
Autor:
Kentaro Miura, Kimihiro Shimizu, Takashi Eguchi, Sachie Koike, Shunichiro Matsuoka, Tetsu Takeda, Kazutoshi Hamanaka, Takeshi Uehara
Publikováno v:
Diagnostic Pathology, Vol 16, Iss 1, Pp 1-8 (2021)
Abstract Background The novel SS18-SSX fusion-specific antibody is reported to have high sensitivity and specificity for the diagnosis of primary synovial sarcoma (SS), which often metastasizes to the lung. Thus far, no study has validated the diagno
Externí odkaz:
https://doaj.org/article/ee53faef000040a2b9588887866a36be
Autor:
Hisao Imai, Kimihiro Shimizu, Osamu Kawashima, Hideki Endoh, Kazuyoshi Imaizumi, Yasuhiro Goto, Mitsuhiro Kamiyoshihara, Masayuki Sugano, Ryohei Yamamoto, Shigebumi Tanaka, Atsushi Fujita, Yoshihito Kogure, Yukio Seki, Akira Mogi, Tetsunari Oyama, Koichi Minato, Takayuki Asao, Kyoichi Kaira
Publikováno v:
Cancers, Vol 11, Iss 11, p 1636 (2019)
Various drug-sensitivity markers are potentially responsible for tumor progression and chemotherapy resistance in cancer patients with both epithelial and sarcomatous components; however, the clinicopathological significance of drug-sensitivity marke
Externí odkaz:
https://doaj.org/article/efe4aa7a97a443fbb610f38947a45bfb
Autor:
Tetsu Takeda, Tsutomu Koyama, Kazutoshi Hamanaka, Takeshi Uehara, Kyoko Yamada, Kenji Sano, Takashi Eguchi, Shunichiro Matsuoka, Kimihiro Shimizu
Publikováno v:
Thoracic Cancer
Thoracic Cancer, Vol 12, Iss 5, Pp 711-714 (2021)
Thoracic Cancer, Vol 12, Iss 5, Pp 711-714 (2021)
Although the number of patients diagnosed with synchronous multiple primary lung cancer is growing because of increased screening and improved imaging technology, synchronous triple primary lung cancer with different histological tumor subtypes occur
Autor:
Tetsunari Oyama, Ken Shirabe, Kimihiro Shimizu, Tadashi Handa, Mariko Tsukagoshi, Takaaki Sano, Satoshi Yokoo, Kyoichi Kaira, Takehiko Yokobori, Tetsuya Higuchi, Maria Togo
Publikováno v:
British Journal of Cancer
Background Lately, immune checkpoint proteins, such as programmed death 1 (PD-1) and its ligand-1 (PD-L1), have garnered attention as a new target in oral squamous cell carcinoma (OSCC). Reportedly, fluoro-d-glucose (FDG)-uptake alteration by anti-PD
Autor:
Mitsuhiro Kamiyoshihara, Shigefumi Tanaka, Kyoichi Kaira, Takayuki Asao, Kazuyoshi Imaizumi, Kimihiro Shimizu, Ken Shirabe, Atsushi Fujita, Hideki Endoh, Masayuki Sugano, Osamu Kawashima, Yoshihito Kogure, Tetsunari Oyama, Hisao Imai
Publikováno v:
Anticancer Research. 40:261-269
Background Pulmonary pleomorphic carcinoma (PPC) is a rare aggressive neoplasm, with dismal prognosis. Whether tumor immunity is associated with the progressive biological behavior of PPC remains unclear. The purpose of this study was to examine the
Autor:
Tetsunari Oyama, Kimihiro Shimizu, Takayuki Asao, Tetsuya Higuchi, Ken Shirabe, Yoshito Tsushima, Takehiko Yokobori, Kyoichi Kaira, Takeshi Hisada
Publikováno v:
Molecular Imaging and Biology. 22:1078-1086
3-[18F]Fluoro-α-methyl-L-tyrosine ([18F]FAMT) is an amino acid positron emission tomography (PET) tracer specific for cancer detection by assessment of tumor amino acid metabolism. Little is known on whether or not the uptake of [18F]FAMT within can
Autor:
Sachie Koike, Kazutoshi Hamanaka, Takeshi Uehara, Shunichiro Matsuoka, Kimihiro Shimizu, Takashi Eguchi, Tetsu Takeda, Kentaro Miura
Publikováno v:
Diagnostic Pathology
Diagnostic Pathology, Vol 16, Iss 1, Pp 1-8 (2021)
Diagnostic Pathology, Vol 16, Iss 1, Pp 1-8 (2021)
Background The novel SS18-SSX fusion-specific antibody is reported to have high sensitivity and specificity for the diagnosis of primary synovial sarcoma (SS), which often metastasizes to the lung. Thus far, no study has validated the diagnostic effi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dce341accfcd593acb7e4eb9f714f9e
https://doi.org/10.21203/rs.3.rs-386235/v1
https://doi.org/10.21203/rs.3.rs-386235/v1
Autor:
Akira Mogi, Seshiru Nakazawa, Bolag Altan, Susumu Rokudai, Kai Obayashi, Arito Yamane, Yoichi Ohtaki, Navchaa Gombodorj, Kimihiro Shimizu, Misaki Iijima, Kyoichi Kaira, Takehiko Yokobori, Reika Kawabata-Iwakawa, Takayuki Kosaka, Masahiko Nishiyama, Hiroyuki Kuwano, Toshiteru Nagashima, Ken Shirabe, Toshiki Yajima
Publikováno v:
Oncotarget
// Yoichi Ohtaki 1, 2, 3 , Kimihiro Shimizu 1, 2 , Reika Kawabata-Iwakawa 4 , Navchaa Gombodorj 2 , Bolag Altan 5 , Susumu Rokudai 4 , Arito Yamane 4 , Kyoichi Kaira 5 , Takehiko Yokobori 6 , Toshiteru Nagashima 1, 2 , Kai Obayashi 1, 2 , Seshiru Nak
Autor:
Tetsunari Oyama, Takayuki Asao, Hideki Endoh, Masayuki Sugano, Osamu Kawashima, Shigefumi Tanaka, Akira Shimizu, Kyoichi Kaira, Mitsuhiro Kamiyoshihara, Kimihiro Shimizu, Yoshihito Kogure, Kazuyoshi Imaizumi, Atsushi Fujita, Akira Mogi
Publikováno v:
Anticancer Research. 39:395-403
Background/aim The β2-adrenergic receptor (β2AR) is highly expressed in various human cancers and has been linked to tumor growth and metastases. Although β2AR is considered a novel therapeutic target of human neoplasms, the clinicopathological si
Autor:
Yoichi Ohtaki, Takayuki Kosaka, Akira Mogi, Shinsuke Kitahara, Tetsunari Oyama, Jun Atsumi, Kimihiro Shimizu, Toshiki Yajima, Kyoichi Kaira, Takayuki Asao, Tetsuya Higuchi
Publikováno v:
European Journal of Cancer. 101:181-190
2-Deoxy-2-[fluorine-18] fluoro- d -glucose (18F-FDG) positron emission tomography (PET) is a useful modality for the assessment of tumour glucose metabolism by upregulation by hypoxia. Little is known whether the uptake of 18F-FDG within cancer cells